Literature DB >> 2207345

Cathepsin D in breast cancer.

H Rochefort1.   

Abstract

Cathepsin D is an acidic lysosomal protease present in all cells. In estrogen receptor positive and negative breast cancer cell lines, the mRNA coding for pro-cathepsin D is overexpressed and sorting and maturation of the pro-enzyme are altered, leading to accumulation of the active proteinase in large endosomes and to secretion of the precursor (52K protein). In MCF7 cells, the cathepsin D mRNA is induced directly and transcriptionally by estrogens and indirectly by growth factors. In vitro, pro-cathepsin D is an autocrine mitogen on breast cancer cells and can be auto-activated to degrade extracellular matrix and proteoglycans and to activate other proteinases in acidic microenvironments. In patients, there is a significant correlation between high cathepsin D concentrations in the cytosol of primary breast cancer and development of metastasis. This marker is independent of other prognostic factors and appears to be particularly useful in lymph node-negative tumors. These results suggest that overexpression and possible derouting of cathepsin D plays an important role in invasion and metastasis of breast cancer.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2207345     DOI: 10.1007/bf01806570

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  40 in total

1.  Cathepsin D: an independent prognostic factor for metastasis of breast cancer.

Authors:  F Spyratos; T Maudelonde; J P Brouillet; M Brunet; A Defrenne; C Andrieu; K Hacene; A Desplaces; J Rouëssé; H Rochefort
Journal:  Lancet       Date:  1989-11-11       Impact factor: 79.321

2.  Increased secretion, altered processing, and glycosylation of pro-cathepsin D in human mammary cancer cells.

Authors:  F Capony; C Rougeot; P Montcourrier; V Cavailles; G Salazar; H Rochefort
Journal:  Cancer Res       Date:  1989-07-15       Impact factor: 12.701

3.  Cloning and sequence analysis of cDNA for human cathepsin D.

Authors:  P L Faust; S Kornfeld; J M Chirgwin
Journal:  Proc Natl Acad Sci U S A       Date:  1985-08       Impact factor: 11.205

4.  Cathepsin-D in human endometrium: induction by progesterone and potential value as a tumor marker.

Authors:  T Maudelonde; P Martinez; J P Brouillet; F Laffargue; A Pages; H Rochefort
Journal:  J Clin Endocrinol Metab       Date:  1990-01       Impact factor: 5.958

5.  Breast cancer-associated pS2 protein: synthesis and secretion by normal stomach mucosa.

Authors:  M C Rio; J P Bellocq; J Y Daniel; C Tomasetto; R Lathe; M P Chenard; A Batzenschlager; P Chambon
Journal:  Science       Date:  1988-08-05       Impact factor: 47.728

6.  [Pro-cathepsin D can activate in vitro pro-cathepsin B secreted by ovarian cancers].

Authors:  M Pagano; F Capony; H Rochefort
Journal:  C R Acad Sci III       Date:  1989

7.  Cathepsin D assay in primary breast cancer and lymph nodes: relationship with c-myc, c-erb-B-2 and int-2 oncogene amplification and node invasiveness.

Authors:  J P Brouillet; C Theillet; T Maudelonde; A Defrenne; J Simony-Lafontaine; J Sertour; H Pujol; P Jeanteur; H Rochefort
Journal:  Eur J Cancer       Date:  1990-04       Impact factor: 9.162

8.  Immunoenzymatic assay of Mr 52,000 cathepsin D in 182 breast cancer cytosols: low correlation with other prognostic parameters.

Authors:  T Maudelonde; S Khalaf; M Garcia; G Freiss; J Duporte; M Benatia; H Rogier; F Paolucci; J Simony; H Pujol
Journal:  Cancer Res       Date:  1988-01-15       Impact factor: 12.701

9.  Tamoxifen treatment increases the concentration of 52K-cathepsin D and its precursor in breast cancer tissue.

Authors:  T Maudelonde; J Domergue; C Henquel; G Freiss; J P Brouillet; J Simony; H Pujol; H Rochefort
Journal:  Cancer       Date:  1989-04-01       Impact factor: 6.860

10.  Immunodetection of estrogen receptor and 52,000-dalton protein in fine needle aspirates of breast cancer tumors.

Authors:  V Cavailles; M Garcia; G Salazar; J Domergue; J Simony; H Pujol; H Rochefort
Journal:  J Natl Cancer Inst       Date:  1987-08       Impact factor: 13.506

View more
  21 in total

1.  Evaluation of the prognostic significance of nm23/NDP kinase and cathepsin D in anal carcinomas. An immunohistochemical study.

Authors:  R Holm; G Tanum
Journal:  Virchows Arch       Date:  1996-05       Impact factor: 4.064

2.  Steroid hormone receptors and their clinical significance in cancer.

Authors:  R I Nicholson; R A McClelland; J M Gee
Journal:  J Clin Pathol       Date:  1995-10       Impact factor: 3.411

Review 3.  Cathepsin B and other proteases in human colorectal carcinoma.

Authors:  J M Jessup
Journal:  Am J Pathol       Date:  1994-08       Impact factor: 4.307

4.  Alpha1-antichymotrypsin and kallistatin hydrolysis by human cathepsin D.

Authors:  D C Pimenta; V C Chen; J Chao; M A Juliano; L Juliano
Journal:  J Protein Chem       Date:  2000-07

5.  Breast ductal lavage for assessment of breast cancer biomarkers.

Authors:  Robert Treat Chatterton; Noah P Parker; Mito Habe-Evans; Michele Bryk; Denise M Scholtens; Seema A Khan
Journal:  Horm Cancer       Date:  2010-08       Impact factor: 3.869

Review 6.  Genes, chromatin, and breast cancer: an epigenetic tale.

Authors:  L M Mielnicki; H L Asch; B B Asch
Journal:  J Mammary Gland Biol Neoplasia       Date:  2001-04       Impact factor: 2.673

7.  MCF-7 breast cancer cells transfected with protein kinase C-alpha exhibit altered expression of other protein kinase C isoforms and display a more aggressive neoplastic phenotype.

Authors:  D K Ways; C A Kukoly; J deVente; J L Hooker; W O Bryant; K J Posekany; D J Fletcher; P P Cook; P J Parker
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

8.  Quantitative immunohistochemical determination of cathepsin-D and its relation with other variables.

Authors:  S Veneroni; M G Daidone; G Di Fronzo; V Cappelletti; D Amadori; A Riccobon; A Paradiso; M Correale; R Silvestrini
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

9.  Comparative biochemical and immunohistochemical studies on the cathepsin D content of human breast cancer.

Authors:  W Remmele; J Sauer-Manthey
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

10.  Prognostic value of total cathepsin D in breast tumors. A possible role in selection of chemoresistant patients.

Authors:  M Namer; A Ramaioli; X Fontana; M C Etienne; M Héry; A Jourlait; G Milano; M Frenay; E François; F Lapalus
Journal:  Breast Cancer Res Treat       Date:  1991-10       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.